[go: up one dir, main page]

SG11201602533QA - Three-pack type dialysis agent containing acetic acid and acetic acid salt - Google Patents

Three-pack type dialysis agent containing acetic acid and acetic acid salt

Info

Publication number
SG11201602533QA
SG11201602533QA SG11201602533QA SG11201602533QA SG11201602533QA SG 11201602533Q A SG11201602533Q A SG 11201602533QA SG 11201602533Q A SG11201602533Q A SG 11201602533QA SG 11201602533Q A SG11201602533Q A SG 11201602533QA SG 11201602533Q A SG11201602533Q A SG 11201602533QA
Authority
SG
Singapore
Prior art keywords
acetic acid
agent containing
pack type
dialysis agent
type dialysis
Prior art date
Application number
SG11201602533QA
Inventor
Hiroshi Noguchi
Michiko Myose
Junya Kikuishi
Hideyuki Aoyama
Mina Hashimoto
Yusuke Yoshimoto
Original Assignee
Tomita Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomita Pharma filed Critical Tomita Pharma
Publication of SG11201602533QA publication Critical patent/SG11201602533QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201602533QA 2013-10-02 2014-10-02 Three-pack type dialysis agent containing acetic acid and acetic acid salt SG11201602533QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013207382A JP5517322B1 (en) 2013-10-02 2013-10-02 Three-part dialysis agent containing acetic acid and acetate
PCT/JP2014/076373 WO2015050189A1 (en) 2013-10-02 2014-10-02 Three-pack type dialysis agent containing acetic acid and acetic acid salt

Publications (1)

Publication Number Publication Date
SG11201602533QA true SG11201602533QA (en) 2016-05-30

Family

ID=51031258

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602533QA SG11201602533QA (en) 2013-10-02 2014-10-02 Three-pack type dialysis agent containing acetic acid and acetic acid salt

Country Status (6)

Country Link
JP (1) JP5517322B1 (en)
KR (1) KR102363179B1 (en)
MY (2) MY178249A (en)
PH (1) PH12016500571B1 (en)
SG (1) SG11201602533QA (en)
WO (1) WO2015050189A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5376480B1 (en) 2012-10-10 2013-12-25 富田製薬株式会社 A dialysis agent containing acetic acid and acetate, and two-agent dialysis agent using the same
JP5517321B1 (en) * 2013-10-02 2014-06-11 富田製薬株式会社 Solid dialysis agent A containing alkali metal diacetate, and two-agent type low-acetate dialysis agent using the same
WO2015072494A1 (en) 2013-11-12 2015-05-21 扶桑薬品工業株式会社 Novel sodium diacetate crystal and solid dialysis preparation comprising said crystal
JP6562336B2 (en) * 2014-12-11 2019-08-21 富田製薬株式会社 Method for producing granulated material used for dialysis agent A
KR102624996B1 (en) * 2015-03-31 2024-01-12 감브로 룬디아 아베 Package for acid dialysate concentrate containing citrate and glucose
JP6467285B2 (en) * 2015-05-13 2019-02-13 富田製薬株式会社 Granules for agent A for dialysis and method for producing the same
CN109890370B (en) * 2016-10-28 2021-06-29 富田制药株式会社 Agent A for hemodialysis
JP6312957B1 (en) * 2016-10-28 2018-04-18 富田製薬株式会社 Agent A for hemodialysis
CN110522763A (en) * 2019-10-08 2019-12-03 四川太平洋药业有限责任公司 A kind of Multiple electrolytes injection and preparation process
CN119564851B (en) * 2024-12-05 2025-08-22 广州骐骥生物科技有限公司 A glacial acetic acid dialysis concentrate and its preparation method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0599464A (en) 1991-10-08 1993-04-20 Nec Corp Air shower device
EP0613688B2 (en) 1993-02-19 2004-08-18 Wilfried Dr.-Ing. Schäl Process for preparing a bicarbonate containing dialysis liquid for the hemodialysis
JP2809971B2 (en) 1993-07-06 1998-10-15 扶桑薬品工業株式会社 Hemodialysis preparation
JP3433979B2 (en) * 1993-08-24 2003-08-04 日機装株式会社 Dialysis agent and method for producing the same
JP3619921B2 (en) 1996-09-13 2005-02-16 富田製薬株式会社 Bicarbonate solid dialysis agent
CN1152668C (en) * 1997-08-22 2004-06-09 清水制药株式会社 Preparations containing glucose
JP3586767B2 (en) * 2000-04-06 2004-11-10 富田製薬株式会社 Preparation method and adjustment device for dialysate
JP5204359B2 (en) 2001-09-28 2013-06-05 味の素株式会社 Dialysis agent and method for producing the same
CN1189180C (en) * 2003-04-30 2005-02-16 广州康盛生物科技有限公司 Bicarbonate dry powder composition for hemodialysis
WO2005094918A1 (en) 2004-03-30 2005-10-13 Nipro Corporation Solid pharmaceutical preparation for dialysis
WO2010112570A1 (en) 2009-03-31 2010-10-07 Gambro Lundia Ab Dialysis solution
JP5099464B1 (en) * 2011-12-29 2012-12-19 富田製薬株式会社 Bicarbonate ion concentration-variable dialysate preparation device and preparation method, bicarbonate ion concentration-variable dialysate, and bicarbonate ion concentration-variable dialyzing system

Also Published As

Publication number Publication date
KR102363179B1 (en) 2022-02-14
MY178249A (en) 2020-10-07
PH12016500571A1 (en) 2016-06-20
MY176214A (en) 2020-07-24
JP2015070908A (en) 2015-04-16
WO2015050189A1 (en) 2015-04-09
KR20160064181A (en) 2016-06-07
PH12016500571B1 (en) 2016-06-20
JP5517322B1 (en) 2014-06-11

Similar Documents

Publication Publication Date Title
IL269877B (en) Blood pump systems and methods
SG11201602533QA (en) Three-pack type dialysis agent containing acetic acid and acetic acid salt
EP3019154A4 (en) Nicotine salt with m eta-salicylic acid
IL239203A0 (en) Semifluorocarbon compound containing contrast agent
GB201314953D0 (en) Catheter Assembley
EP2941246A4 (en) Boronic acid derivatives and therapeutic uses thereof
SG11201508857RA (en) Utility application delivery platform
SG11201600473UA (en) Amino acid derivatives
SG2013073051A (en) Iodine-based etching solution and etching method
SG11201506713TA (en) 2-acylaminothiazole derivative and salt thereof
GB2510497B (en) Catheter
EP2999341A4 (en) Stabilized hypochlorous acid solution and use thereof
GB201322408D0 (en) Continuous use syringe filter
PL3004643T3 (en) Metering pump and metering system
SG11201507648RA (en) Liquid quick-setting agent
TWI562796B (en) Catheter system
GB201305761D0 (en) Blood Pump
ZA201503171B (en) Modified hyaluronic acid derivatives and use thereof
PL2983509T3 (en) Silica based salt solution delivery system
GB201305758D0 (en) Blood Pump
SG11201406942SA (en) Trans-2-decenoic acid derivative and drug containing same
PL2952190T3 (en) Stable aqueous solution
IL233698B (en) Multishape catheter
EP2952189A4 (en) Clear aqueous solution
PL3075738T3 (en) Glycyrrhetinic acid derivative and use thereof